会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Electrically conductive composition
    • 导电组合物
    • US5552216A
    • 1996-09-03
    • US132315
    • 1993-10-06
    • Toshiya SugimotoMinoru SuezakiTokushige ShitiriKouji Maruyama
    • Toshiya SugimotoMinoru SuezakiTokushige ShitiriKouji Maruyama
    • C09D5/24H01B1/12B32B5/16B32B27/30H01B1/20
    • H01B1/128C09D5/24Y10T428/256Y10T428/31935
    • An electrically conductive composition of the invention comprises 100 parts by weight of a (meth)acrylate compound possessing at least two (meth)acryloyl groups, 1 to 100 parts by weight of an anilinic electrically conductive polymer, and 0.1 to 20 parts by weight of a photopolymerization initiator sensitized by active rays. This electrically conductive composition may also comprise an unsaturated compound possessing any one group selected from the group consisting of a phosphoric acid group, a sulfonic acid group and a carboxyl group. Between the surface of a form to be coated and the coating layer made of the electrically conductive composition formed thereon, an inorganic electrically conductive layer composed of the tin oxide powder containing antimony with mean particle size of 0.01 to 0.4 .mu.m, or the barium sulfate powder coated with tin oxide containing antimony with mean particle size of 0.01 to 2 .mu.m, and a synthetic resin may be provided.
    • 本发明的导电组合物包含100重量份具有至少两个(甲基)丙烯酰基的(甲基)丙烯酸酯化合物,1至100重量份的苯胺系导电聚合物和0.1至20重量份的 由活性光线敏化的光聚合引发剂。 该导电性组合物还可以包含具有选自磷酸基,磺酸基和羧基中的任何一个基团的不饱和化合物。 在待涂覆形式的表面和由其上形成的导电组合物制成的涂层之间,由含有平均粒径为0.01至0.4μm的锑的氧化锡粉末或硫酸钡形成的无机导电层 粉末涂覆有平均粒度为0.01〜2μ​​m的含锑的氧化锡,可以提供合成树脂。
    • 10. 发明申请
    • IMMUNITY INDUCER
    • 免疫电感
    • US20130183356A1
    • 2013-07-18
    • US13812000
    • 2011-07-28
    • Jinyan ChengKouji Maruyama
    • Jinyan ChengKouji Maruyama
    • A61K33/42
    • A61K33/42A61K9/0024A61K9/2095
    • The purpose is to provide an immunity-inducing agent which can be implanted or injected in vivo by a simple operation and is capable of activating the in vivo immunological actions without causing adverse side effects. An immunity-inducing agent comprising β-tricalcium phosphate (β-TCP) having a porosity of 50% or less is implanted or injected in vivo, particularly in the vicinity of a lesion area (non-lesion area) such as cancer. Lymphocytes such as T cells, B cells and NK cells or a dendritic cell can be induced in the vicinity of β-TCP, and a lymphadenoid tissue is formed in which lymphocytes are localized at a high density. Examples of the dosage form of the immunity-inducing agent include particles or granules having a particle or grain size of equal to or greater than 0.05 μm and less than 25 μm, as well as tablets or columellas.
    • 其目的是提供能够通过简单操作在体内植入或注射的免疫诱导剂,并且能够激活体内免疫学作用而不引起不良副作用。 具有孔隙率为50%以下的β-磷酸三钙(β-TCP)的免疫诱导剂在体内植入或注射,特别是在病变区域(非损伤区域)如癌症附近。 可以在β-TCP附近诱导淋巴细胞如T细胞,B细胞和NK细胞或树突状细胞,并且形成淋巴细胞以高密度定位的淋巴细胞组织。 免疫诱导剂的剂型的实例包括具有等于或大于0.05μm和小于25μm的颗粒或颗粒的颗粒或颗粒,以及片剂或花粉。